 |
|
|
 |
Information For Professionals: Testing For Hepatitis C Infection
Consent for testing should be obtained in a manner consistent with that for other medical care and
services provided in the same setting, and should include measures to prevent unwanted disclosure of test results to others.
Persons should be provided with information regarding exposures associated with the transmission of HCV, including behaviors
or exposures that might have occurred infrequently or many years ago; the test procedures and the meaning of test results; the
nature of hepatitis C and chronic liver disease; the benefits of detecting infection early; available medical treatment; and potential
adverse consequences of testing positive, including disrupted personal relationships and possible discriminatory action (e.g., loss
of employment, insurance, and educational opportunities). more
|
|
Information For Professionals: Clinical Management & Treatment Of Hepatitis C
HCV-positive patients should be evaluated for the presence and severity of chronic liver disease. Initial
evaluation for presence of disease should include multiple measurements of ALT at regular intervals, because ALT activity
fluctuates in persons with chronic hepatitis C. Patients with chronic hepatitis C should be evaluated for the severity of their liver
disease and for possible treatment. more
|
|
|
|
Ebola Update: Gabon Decides To Seal Off Northeastern Province
According to the latest World Health Organization figures, 33 confirmed cases have been reported
since the onset of the outbreak and there have been 24 deaths -- 17 in Gabon and 7 in the neighboring Republic of the Congo.
Fifteen more suspected cases are being monitored in Gabon. more
|
|
Stress Myocardial Perfusion Imaging Is More Accurate Predictor Of Heart Attack And Cardiac Death
Than Clinical Assessment Alone
The results of a new study show that a noninvasive imaging technique, called stress myocardial
perfusion imaging (or stress MPI), can help to more accurately detect crucial warning signs of future cardiac events in patients
with diabetes. The results of the study which are published in the current issue of Circulation: Journal of the American Heart
Association, show that stress MPI is more accurate in predicting future cardiac events than clinical assessment alone. more
|
|
Drug Watch: Hepatitis C Protease Inhibitor Under Development
Eli Lilly and Company and Vertex Pharmaceuticals Incorporated announced today that they have
selected LY570310 (VX-950), a novel small molecule protease inhibitor for the potential treatment of hepatitis C virus (HCV)
infection, as a development candidate. more
|
|
|
